Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
Archil Jaliashvili: NATO Blood Panel Warns That The System Won’t Hold Under Real Surge Conditions
Archil Jaliashvili/LinkedIn
Mar 21, 2026, 17:07

Archil Jaliashvili: NATO Blood Panel Warns That The System Won’t Hold Under Real Surge Conditions

Archil Jaliashvili, Co-owner, General Manager of SkinAI, Co-Chief Executive Officer at GeoBio Pharm, shared a post on LinkedIn about a recent article by Nadira Frescalinea et al, published in The Lancet:

”Blood is not just a medical resource.

It’s infrastructure. It’s strategy. It’s sovereignty.

The warning from the NATO Blood Panel (via AABB, The Lancet) is clear:

The system won’t hold under real surge conditions.

  • Reality
  • 42-day shelf life
  • Cold chain dependency
  • Fragile logistics

Works in hospitals. Fails in disruption.

  • Where it matters most
  • Pre-hospital
  • Battlefield
  • Accidents
  • Early transfusion equals survival

The gap:

It’s not donors.

It’s function delivery under pressure.

BHOC – what we believe

BHOC – Biological Hemoglobin Oxygen Carrier can fill the gap:

  • Restore blood oxygenation immediately
  • Controlled oxygen delivery
  • Low-risk side effects
  • No blood typing, no cold chain
  • Rapid deployment where it matters most

Early oxygen delivery saves lives.

Top of that
What’s your opinion why we transfuse blood ?

What we treat ? How we define needs and outcome ?

Drop your idea, thought , share your opinion”

Title: Call to enhance civilian and military blood preparedness

Authors: Nadira Frescalinea, Andrew Beckett, Michael C Reade

Read the Full Article on The Lancet

Archil Jaliashvili: NATO Blood Panel Warns That The System Won’t Hold Under Real Surge Conditions

Stay updated on all scientific advances with Hemostasis Today.

AABB Andrew Beckett Archil Jaliashvili BHOC Biological Hemoglobin Oxygen Carrier Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine Michael C. Reade Nadira Frescalinea NATO Blood Panel Plasma Donation The Lancet Transfusion Medicine
NewsFeed